RELMADA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
RELMADA THERAPEUTICS, INC. (RLMD) had Shares Outstanding (Cover Page) of 106.67 million shares as of 2026-08-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-04: Entity Common Stock, Shares Outstanding 106.67M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 104.89M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 104.89M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 73.33M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 106.67M shares 10-Q · filed 2026-08-06 |
| 2026-05-07 | 104.89M shares 10-Q · filed 2026-05-12 |
| 2026-03-16 | 104.89M shares 10-K · filed 2026-03-19 |
| 2025-11-10 | 73.33M shares 10-Q · filed 2025-11-13 |
| 2025-08-04 | 33.19M shares 10-Q · filed 2025-08-07 |
| 2025-05-07 | 33.19M shares 10-Q · filed 2025-05-12 |
| 2025-03-25 | 33.19M shares 10-K · filed 2025-03-27 |
| 2024-11-04 | 30.17M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 30.17M shares 10-Q · filed 2024-08-07 |
| 2024-05-03 | 30.17M shares 10-Q · filed 2024-05-08 |
| 2024-03-15 | 30.17M shares 10-K · filed 2024-03-19 |
| 2023-11-06 | 30.10M shares 10-Q · filed 2023-11-08 |
| 2023-08-03 | 30.10M shares 10-Q · filed 2023-08-08 |
| 2023-05-09 | 30.10M shares 10-Q · filed 2023-05-11 |
| 2023-03-20 | 30.10M shares 10-K · filed 2023-03-23 |
| 2022-11-07 | 30.10M shares 10-Q · filed 2022-11-10 |
| 2022-08-09 | 30.06M shares 10-Q · filed 2022-08-11 |
| 2022-05-02 | 29.99M shares 10-Q · filed 2022-05-05 |
| 2022-03-21 | 29.37M shares 10-K · filed 2022-03-25 |
| 2021-11-10 | 17.53M shares 10-Q · filed 2021-11-12 |
| 2021-08-06 | 17.47M shares 10-Q · filed 2021-08-10 |
| 2021-05-07 | 16.80M shares 10-Q · filed 2021-05-12 |
| 2021-03-15 | 16.75M shares 10-K · filed 2021-03-24 |
| 2020-11-09 | 16.24M shares 10-Q · filed 2020-11-12 |
| 2020-08-05 | 16.02M shares 10-Q · filed 2020-08-12 |
| 2020-05-13 | 15.20M shares 10-Q · filed 2020-05-15 |
| 2020-03-26 | 14.94M shares 10-KT · filed 2020-03-26 |
| 2019-11-08 | 10.28M shares 10-Q · filed 2019-11-13 |
| 2019-09-24 | 39.58M shares 10-K · filed 2019-09-24 |
| 2019-05-14 | 33.26M shares 10-Q · filed 2019-05-15 |
| 2019-02-13 | 30.27M shares 10-Q · filed 2019-02-13 |
| 2018-11-13 | 28.43M shares 10-Q · filed 2018-11-13 |
| 2018-09-28 | 12.55M shares 10-K · filed 2018-09-28 |
| 2018-05-14 | 12.55M shares 10-Q · filed 2018-05-14 |
| 2018-02-12 | 12.55M shares 10-Q · filed 2018-02-12 |
| 2017-11-14 | 12.55M shares 10-Q · filed 2017-11-14 |
| 2017-09-28 | 12.55M shares 10-K · filed 2017-09-28 |
| 2017-05-15 | 12.04M shares 10-Q · filed 2017-05-15 |
| 2017-01-20 | 12.04M shares 10-Q · filed 2017-02-10 |
| 2016-11-10 | 12.04M shares 10-Q · filed 2016-11-10 |
| 2016-09-09 | 12.04M shares 10-K · filed 2016-09-09 |
| 2016-05-09 | 12.02M shares 10-Q · filed 2016-05-09 |
| 2016-02-05 | 12.00M shares 10-Q · filed 2016-02-05 |
| 2015-11-06 | 11.55M shares 10-Q · filed 2015-11-06 |
| 2015-09-11 | 10.81M shares 10-K · filed 2015-09-11 |
| 2015-05-15 | 53.74M shares 10-Q · filed 2015-05-15 |
| 2015-02-13 | 53.68M shares 10-Q · filed 2015-02-13 |
| 2014-11-07 | 50.77M shares 10-Q · filed 2014-11-07 |
| 2014-09-02 | 40.30M shares 10-KT · filed 2014-09-09 |
| 2014-04-14 | 28.50M shares 10-Q · filed 2014-04-15 |
| 2014-01-14 | 28.50M shares 10-Q · filed 2014-01-13 |
| 2013-12-13 | 28.50M shares 10-K · filed 2013-12-16 |
| 2013-07-10 | 23.50M shares 10-Q · filed 2013-07-12 |
| 2013-05-02 | 23.50M shares 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |